{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T04:07:18Z","timestamp":1785211638259,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Tanabe Mitsubishi Pharmacological Inc, Japan"},{"DOI":"10.13039\/501100005945","name":"Hirosaki University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.metabol.2020.154232","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T19:29:06Z","timestamp":1586892546000},"page":"154232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and \u03b2-cell volume density in spontaneously type 2 diabetic Goto-Kakizaki rats"],"prefix":"10.1016","volume":"107","author":[{"given":"Danyang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Osonoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroku","family":"Yagihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.metabol.2020.154232_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s125-002-8248-z","article-title":"Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients","volume":"45","author":"Sakuraba","year":"2002","journal-title":"Diabetologia."},{"issue":"1","key":"10.1016\/j.metabol.2020.154232_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes."},{"issue":"7","key":"10.1016\/j.metabol.2020.154232_bb0015","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1007\/s00125-011-2118-4","article-title":"Pancreatic alpha cell mass in European subjects with type 2 diabetes","volume":"54","author":"Henquin","year":"2011","journal-title":"Diabetologia."},{"issue":"7","key":"10.1016\/j.metabol.2020.154232_bb0020","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2337\/dc13-2018","article-title":"Involvement of oxidative stress-induced DNA damage, endoplasmic reticulum stress, and autophagy deficits in the decline of \u03b2-cell mass in Japanese type 2 diabetic patients","volume":"37","author":"Mizukami","year":"2014","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.metabol.2020.154232_bb0025","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","article-title":"\u03b2-Cell loss and \u03b2-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition","volume":"178","author":"Jurgens","year":"2011","journal-title":"Am J Pathol."},{"issue":"3","key":"10.1016\/j.metabol.2020.154232_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/13506129.2014.937857","article-title":"Islet amyloid with macrophage migration correlates with augmented \u03b2-cell deficits in type 2 diabetic patients","volume":"21","author":"Kamata","year":"2014","journal-title":"Amyloid."},{"issue":"9","key":"10.1016\/j.metabol.2020.154232_bb0035","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/jc.2016-3735","article-title":"Pancreas atrophy and islet amyloid deposition in patients with elderly-onset type 2 diabetes","volume":"102","author":"Xin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.metabol.2020.154232_bb0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s001250051322","article-title":"Autonomic regulation of islet hormone secretion \u2013 implications for health and disease","volume":"43","author":"Ahr\u00e9n","year":"2000","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.metabol.2020.154232_bb0045","first-page":"565","article-title":"Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function","volume":"22","author":"Gilon","year":"2001","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.metabol.2020.154232_bb0050","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.neuroscience.2005.10.055","article-title":"A quantitative analysis of the sensory and sympathetic innervation of the mouse pancreas","volume":"137","author":"Lindsay","year":"2006","journal-title":"Neuroscience."},{"issue":"1","key":"10.1016\/j.metabol.2020.154232_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ecl.2012.11.001","article-title":"Novel approaches to studying the role of innervation in the biology of pancreatic islets","volume":"42","author":"Rodriguez-Diaz","year":"2013","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.metabol.2020.154232_bb0060","first-page":"87","article-title":"Neural regulation of pancreatic islet cell mass and function. Diabetes Obes Metab","volume":"1","author":"Thorens","year":"2014","journal-title":"Suppl"},{"issue":"3","key":"10.1016\/j.metabol.2020.154232_bb0065","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1210\/endo-80-3-530","article-title":"Effects of stimulation of the vagus nerve on insulin secretion","volume":"80","author":"Kaneto","year":"1967","journal-title":"Endocrinology."},{"issue":"2","key":"10.1016\/j.metabol.2020.154232_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0301-0082(89)90037-3","article-title":"Nervous regulation of metabolism","volume":"33","author":"Niijima","year":"1989","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.metabol.2020.154232_bb0075","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/gast.1996.v110.pm8608899","article-title":"Ventromedial hypothalamic lesion-induced vagal hyperactivity stimulates rat pancreatic cell proliferation","volume":"110","author":"Kiba","year":"1996","journal-title":"Gastroenterology."},{"issue":"5","key":"10.1016\/j.metabol.2020.154232_bb0080","doi-asserted-by":"crossref","first-page":"E786","DOI":"10.1152\/ajpendo.00202.2010","article-title":"Vagal control of pancreatic \u00df-cell proliferation","volume":"299","author":"Lausier","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5905","key":"10.1016\/j.metabol.2020.154232_bb0085","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.1163971","article-title":"Regulation of pancreatic beta cell mass by neuronal signals from the liver","volume":"322","author":"Imai","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.metabol.2020.154232_bb0090","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-017-01869-7","article-title":"Neuronal signals regulate obesity induced \u03b2-cell proliferation by FoxM1 dependent mechanism","volume":"8","author":"Yamamoto","year":"2017","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.metabol.2020.154232_bb0095","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.metabol.2020.154232_bb0100","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/db16-0284","article-title":"Human. Type 1 diabetes is characterized by an early, marked, sustained, and islet-selective loss of sympathetic nerves","volume":"65","author":"Mundinger","year":"2016","journal-title":"Diabetes."},{"issue":"1\u20133","key":"10.1016\/j.metabol.2020.154232_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-0115(99)00044-0","article-title":"Islet neuronal abnormalities associated with impaired insulin secretion in type 2 diabetes in the Chinese hamster","volume":"82","author":"Kohnert","year":"1999","journal-title":"Regul Pept"},{"issue":"4","key":"10.1016\/j.metabol.2020.154232_bb0110","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/diab.40.4.486","article-title":"Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes","volume":"40","author":"Portha","year":"1991","journal-title":"Diabetes."},{"issue":"2","key":"10.1016\/j.metabol.2020.154232_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9440(10)65596-4","article-title":"Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus","volume":"153","author":"Koyama","year":"1998","journal-title":"Am J Pathol"},{"issue":"1\u20133","key":"10.1016\/j.metabol.2020.154232_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejphar.2012.09.024","article-title":"A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations","volume":"696","author":"Fukuda-Tsuru","year":"2012","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.metabol.2020.154232_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030555","article-title":"Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models","volume":"7","author":"Liang","year":"2012","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.metabol.2020.154232_bb0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejphar.2012.07.030","article-title":"Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats","volume":"691","author":"Inaba","year":"2012","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.metabol.2020.154232_bb0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00428-007-0508-2","article-title":"Augmented beta cell loss and mitochondrial abnormalities in sucrose-fed GK rats","volume":"452","author":"Mizukami","year":"2008","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.metabol.2020.154232_bb0140","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/jnc.13439","article-title":"The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes","volume":"136","author":"Tsuboi","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.metabol.2020.154232_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.irn.2016.03.006","article-title":"Glucotoxic mechanisms and related therapeutic approaches","volume":"127","author":"Yagihashi","year":"2016","journal-title":"Int Rev Neurobiol."},{"key":"10.1016\/j.metabol.2020.154232_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2840-12-85","article-title":"Remodelling of the intracardiac ganglia in diabetic Goto-Kakizaki rats: an anatomical study","volume":"12","author":"Batulevicius","year":"2013","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"10.1016\/j.metabol.2020.154232_bb0155","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2337\/dc14-1698","article-title":"Corneal confocal microscopy shows an improvement in small-fiber neuropathy in subjects with type 1 diabetes on continuous subcutaneous insulin infusion compared with multiple daily injection","volume":"38","author":"Azmi","year":"2015","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.metabol.2020.154232_bb0160","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00424-003-1202-0","article-title":"The sodium\/glucose cotransport family SLC5","volume":"447","author":"Wright","year":"2004","journal-title":"Pflugers Arch"},{"issue":"3","key":"10.1016\/j.metabol.2020.154232_bb0165","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2018.03.199","article-title":"GLP-1 receptor agonist liraglutide exerts central action to induce \u03b2-cell proliferation through medulla to vagal pathway in mice","volume":"499","author":"Kumari","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.metabol.2020.154232_bb0170","doi-asserted-by":"crossref","first-page":"G671","DOI":"10.1152\/ajpgi.00348.2017","article-title":"Lixisenatide requires a functional gut-vagus nerve-brain axis to trigger insulin secretion in controls and type 2 diabetic mice","volume":"315","author":"Charpentier","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"10.1016\/j.metabol.2020.154232_bb0175","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1507\/endocrj.EJ17-0065","article-title":"Effect of canagliflozin on circulating active GLP-1 levels in patients with type 2 diabetes: a randomized trial","volume":"64","author":"Takebayashi","year":"2017","journal-title":"Endocr J"},{"issue":"9","key":"10.1016\/j.metabol.2020.154232_bb0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1463-1326.2008.00893.x","article-title":"Suppression of post-prandial hyperglycaemia by pioglitazone improved islet fibrosis and macrophage migration in the Goto-Kakizaki rat","volume":"10","author":"Mizukami","year":"2008","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.metabol.2020.154232_bb0185","doi-asserted-by":"crossref","first-page":"E376","DOI":"10.1152\/ajpendo.00565.2012","article-title":"Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways","volume":"305","author":"Nishizawa","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.metabol.2020.154232_bb0190","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/oby.2012.59","article-title":"Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats","volume":"20","author":"Devenny","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.metabol.2020.154232_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151511","article-title":"Ipragliflozin improves hepatic steatosis in obese mice and liver dysfunction in type 2 diabetic patients irrespective of body weight reduction","volume":"11","author":"Komiya","year":"2016","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.metabol.2020.154232_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.metabol.2018.02.002","article-title":"Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes","volume":"85","author":"Garvey","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2020.154232_bb0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2015.11.019","article-title":"Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice","volume":"420","author":"Millar","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.metabol.2020.154232_bb0210","doi-asserted-by":"crossref","first-page":"123130","DOI":"10.1172\/jci.insight.123130","article-title":"SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms","volume":"4","author":"Osataphan","year":"2019","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.metabol.2020.154232_bb0215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1507\/endocrj.EJ14-0456","article-title":"Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area","volume":"62","author":"Fujita","year":"2015","journal-title":"Endocr J"},{"issue":"12","key":"10.1016\/j.metabol.2020.154232_bb0220","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archneur.55.12.1513","article-title":"Epidermal nerve fiber density: normative reference range and diagnostic efficiency","volume":"55","author":"McArthur","year":"1998","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.metabol.2020.154232_bb0225","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/dc13-0598","article-title":"Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians","volume":"37","author":"M\u00f8ller","year":"2014","journal-title":"Diabetes Care."}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520300962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049520300962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:26:17Z","timestamp":1758428777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049520300962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":45,"alternative-id":["S0026049520300962"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154232","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and \u03b2-cell volume density in spontaneously type 2 diabetic Goto-Kakizaki rats","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2020.154232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154232"}}